According to a plan being considered by US regulators, some prescription drugs that treat the most common chronic diseases, such as high cholesterol and diabetes, are expected to become over-the-counter drugs.
If the case is finalized, this will be a major policy change, and the U.S. Food and Drug Administration is openly soliciting opinions to find ways to make these drugs more accessible and openly solicit comments until the end of Friday. The FDA will also hold a meeting on this proposal at the end of March.
The FDA's goal is to ensure that people can take the drugs they need while still understanding safety issues.
Experts say that because people are reluctant to take certain medicines prescribed in prescriptions, the therapeutic effects of high blood pressure and other diseases have been destroyed, increasing the cost of medical care in the United States.
About one-third of American adults suffer from high blood pressure, which contributes to heart disease and stroke. According to data from the US Centers for Disease Control and Prevention, in the United States, the cost of medical treatment for hypertension was approximately $76 billion in 2010.
According to the FDA, about one-third of hypertensive patients stop taking the drug.
The problem with having these drugs purchased without prescription is that many drugs require patients to understand the complexities of the disease they are suffering from, or more precisely when they are taking drugs to ensure safe use.
Typical over-the-counter drugs are generally used for the treatment of short-term conditions where the symptoms are easily identifiable, such as headaches or runny nose, and the drugs are sold only with fact sheets or manuals.
However, when taking statin cholesterol-lowering drugs, one needs to know someone's elevated or abnormal lipid levels.
“We have converted statins to over-the-counter drugs in several pilots, but these trials have failed because consumers cannot judge their lipid status,†Janet Woodcock, director of the FDA's drug center, told reporters on Wednesday.
In 2008, the FDA rejected Merck Pharmaceuticals' request to sell the US lipid-lowering (lovastatin) in an over-the-counter form. FDA consultants say patients cannot confirm whether they are suitable for these drugs.
But new technologies may help change this situation.
The FDA said it met with pharmaceutical companies to discuss ways to help people understand drug risks when they go to pharmacies, such as using self-service kiosks, touch-screen tablets, or interactive video.
The FDA stressed that consideration of any over-the-counter changes is still in its infancy.
If the case is finalized, this will be a major policy change, and the U.S. Food and Drug Administration is openly soliciting opinions to find ways to make these drugs more accessible and openly solicit comments until the end of Friday. The FDA will also hold a meeting on this proposal at the end of March.
The FDA's goal is to ensure that people can take the drugs they need while still understanding safety issues.
Experts say that because people are reluctant to take certain medicines prescribed in prescriptions, the therapeutic effects of high blood pressure and other diseases have been destroyed, increasing the cost of medical care in the United States.
About one-third of American adults suffer from high blood pressure, which contributes to heart disease and stroke. According to data from the US Centers for Disease Control and Prevention, in the United States, the cost of medical treatment for hypertension was approximately $76 billion in 2010.
According to the FDA, about one-third of hypertensive patients stop taking the drug.
The problem with having these drugs purchased without prescription is that many drugs require patients to understand the complexities of the disease they are suffering from, or more precisely when they are taking drugs to ensure safe use.
Typical over-the-counter drugs are generally used for the treatment of short-term conditions where the symptoms are easily identifiable, such as headaches or runny nose, and the drugs are sold only with fact sheets or manuals.
However, when taking statin cholesterol-lowering drugs, one needs to know someone's elevated or abnormal lipid levels.
“We have converted statins to over-the-counter drugs in several pilots, but these trials have failed because consumers cannot judge their lipid status,†Janet Woodcock, director of the FDA's drug center, told reporters on Wednesday.
In 2008, the FDA rejected Merck Pharmaceuticals' request to sell the US lipid-lowering (lovastatin) in an over-the-counter form. FDA consultants say patients cannot confirm whether they are suitable for these drugs.
But new technologies may help change this situation.
The FDA said it met with pharmaceutical companies to discuss ways to help people understand drug risks when they go to pharmacies, such as using self-service kiosks, touch-screen tablets, or interactive video.
The FDA stressed that consideration of any over-the-counter changes is still in its infancy.
Ziplock Bag First Aid Kit,Portable Empty Medical Box,Portable Medical First Aid Kits,Medical First-Aid Devices Kits
Shaoxing Weijian Medical Supplies Co.,Ltd. , https://www.wetourmedical.com